EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Swine influenza A virus: challenges and novel vaccine strategies

Erika Petro-Turnquist, Matthew J Pekarek, Eric A Weaver

Frontiers in Cellular and Infection Microbiology · 03.04.2024 · 14

DOI: 10.3389/fcimb.2024.1336013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 03.04.2024. Verfasst von Erika Petro-Turnquist und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Orthomyxoviridae Infections, Influenza A virus. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Food and Agriculture, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Swine Influenza A Virus (IAV-S) imposes a significant impact on the pork industry and has been deemed a significant threat to global public health due to its zoonotic potential. The most effective method of preventing IAV-S is vaccination. While there are tremendous efforts to control and prevent IAV-S in vulnerable swine populations, there are considerable challenges in developing a broadly protective vaccine against IAV-S. These challenges include the consistent diversification of IAV-S, increasing the strength and breadth of adaptive immune responses elicited by vaccination, interfering maternal antibody responses, and the induction of vaccine-associated enhanced respiratory disease after vaccination. Current vaccination strategies are often not updated frequently enough to address the continuously evolving nature of IAV-S, fail to induce broadly cross-reactive responses, are susceptible to interference, may enhance respiratory disease, and can be expensive to produce. Here, we review the challenges and current status of universal IAV-S vaccine research. We also detail the current standard of licensed vaccines and their limitations in the field. Finally, we review recently described novel vaccines and vaccine platforms that may improve upon current methods of IAV-S control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanOrthomyxoviridae InfectionsInfluenza A virusSwine DiseasesAnimalsSwineHumansVaccines, AttenuatedAntibodies, Viral

Stichwörter der Autor:innen

DNAcomputationally designed vaccinesinactivated viruslive attenuated virusnanovaccinereplicon particleswine influenza A virusvectored

Substanzen

Influenza VaccinesVaccines, AttenuatedAntibodies, Viral

Autor:innen und Institutionen

  • Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States.
  • School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States.

Förderung

  • NIAID NIH HHS
  • National Institute of Food and Agriculture
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Petro-Turnquist, E., Pekarek, M. J., & Weaver, E. A. (2024). Swine influenza A virus: challenges and novel vaccine strategies. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1336013

Vancouver

Petro-Turnquist E, Pekarek MJ, Weaver EA. Swine influenza A virus: challenges and novel vaccine strategies. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1336013

BibTeX
@article{PetroTurnquist2024,
  author = {Petro-Turnquist, Erika and Pekarek, Matthew J and Weaver, Eric A},
  title = {Swine influenza A virus: challenges and novel vaccine strategies},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1336013}
}
Kostenlos starten →